DHT.health

Our Abstract Published in Blood! 🎉 With the 66th ASH Annual Meeting just wrapping up, I’m thrilled to share that our abstract, titled "𝑬𝒗𝒂𝒍𝒖𝒂𝒕𝒊𝒏𝒈 𝒕𝒉𝒆 𝑩𝒖𝒓𝒅𝒆𝒏 𝒐𝒇 𝑮𝒍𝒂𝒏𝒛𝒎𝒂𝒏𝒏 𝑻𝒉𝒓𝒐𝒎𝒃𝒂𝒔𝒕𝒉𝒆𝒏𝒊𝒂: 𝑨 𝑺𝒚𝒔𝒕𝒆𝒎𝒂𝒕𝒊𝒄 𝑳𝒊𝒕𝒆𝒓𝒂𝒕𝒖𝒓𝒆 𝑹𝒆𝒗𝒊𝒆𝒘 𝒕𝒐 𝑰𝒅𝒆𝒏𝒕𝒊𝒇𝒚 𝑹𝒆𝒔𝒆𝒂𝒓𝒄𝒉 𝑷𝒓𝒊𝒐𝒓𝒊𝒕𝒊𝒆𝒔" has been published in Blood! While it wasn’t selected for presentation at ASH this year, we’re proud to have contributed this important research to the scientific community. This publication represents a crucial step toward understanding the additional research needed to fully demonstrate the burden GT places on individuals and their families. A huge thank you to the team of co-authors and collaborators— Divyaswathi Peter, George, Sam, Amy, Stacey, Jigar & Ruthvik —for their dedication and input on this project! You can read the full abstract here: https://lnkd.in/dXFu22yv #ASH2024 #Hematology #MedicalResearch #BloodDisorders #GlanzmannThrombasthenia #QualityOfLife #RareDiseases

𝐌𝐢𝐬𝐬𝐞𝐝 𝐮𝐬 𝐚𝐭 𝐈𝐒𝐏𝐎𝐑 𝐄𝐔 2024? 𝐇𝐞𝐫𝐞’𝐬 𝐰𝐡𝐚𝐭 𝐰𝐞 𝐬𝐡𝐚𝐫𝐞𝐝! It was great catching up with so many of you at the conference—we had some fantastic conversations and took away plenty of insights! We also presented two research projects we’re really excited about, tackling important gaps and opportunities in healthcare: 1️⃣ 𝐍𝐈𝐂𝐄’𝐬 𝐄𝐚𝐫𝐥𝐲 𝐕𝐚𝐥𝐮𝐞 𝐀𝐬𝐬𝐞𝐬𝐬𝐦𝐞𝐧𝐭𝐬 𝐟𝐨𝐫 𝐌𝐞𝐝𝐓𝐞𝐜𝐡 - 𝐄𝐯𝐢𝐝𝐞𝐧𝐜𝐞 𝐑𝐞𝐪𝐮𝐢𝐫𝐞𝐦𝐞𝐧𝐭𝐬 ⚫ 41% of technologies assessed received early NHS recommendations, but many weren’t recommended due to evidence gaps. ⚫ Key areas needing more research include healthcare resource use, clinical outcomes, quality of life, and user experience. ⚫ Closing these gaps can help future MedTech innovations achieve recommendations and make a bigger impact. 2️⃣ 𝐆𝐥𝐚𝐧𝐳𝐦𝐚𝐧𝐧 𝐓𝐡𝐫𝐨𝐦𝐛𝐚𝐬𝐭𝐡𝐞𝐧𝐢𝐚 𝐁𝐮𝐫𝐝𝐞𝐧, 𝐐𝐨𝐋 & 𝐂𝐨𝐬𝐭 – 𝐀 𝐒𝐲𝐬𝐭𝐞𝐦𝐚𝐭𝐢𝐜 𝐑𝐞𝐯𝐢𝐞𝐰  🔴 Frequent bleeding events, iron deficiency anemia, and their impact on QoL are significant but there is still limited research. 🔴 Economic data is severely lacking—only 6% of studies covered costs like healthcare resource use and productivity loss. 🔴 More targeted research is needed to fully understand and address the challenges faced by GT patients and their families. If you’d like to learn more, check out the posters attached here or send our team a message. #ISPOREurope #MedTech #RareDisease #Glanzmann

Onto our second poster at ISPOR! This one presents a systematic literature review on the burden, quality of life, and economic cost impact of Glanzmann Thrombasthenia—a rare bleeding disorder where research in HEOR is often limited. If you’re at the conference, we’d love for you to stop by Board 5085 before 10am to check out our findings. Huge thanks to my amazing coauthors Amy, Peter & Stacey for their collaboration and input on this project! And to the The Haemophilia Society & Glanzmann's Research Foundation, Inc. for brining us together to support on this initiative. #ISPOREurope #GlanzmannThrombasthenia #Burden #QualityOfLife #EconomicCost

We are thrilled to be presenting our first of two poster’s at this year’s ISPOR EU! 📊✨ If you’re attending, come by Board 4111 at 6:00 PM to discuss our review of the NICE - National Institute for Health and Care Excellence EVA process. We’d love to connect, exchange insights, and dive into the details of our research. Looking forward to seeing you there! #ISPOREurope #HealthEconomics #HealthPolicy #Research # #EVA

🌟 We’ve arrived at ISPOR EU in Barcelona! 🌟 The DHT.health team is thrilled to be at ISPOR EU, starting off with the first plenary session. We’re looking forward to connecting with fellow professionals and exchanging insights throughout the event. Let’s connect if you’re here too! #ISPOR #ISPOREurope #HEOR #DHTHealth #Barcelona

Our CEO, Sam Bristow, had the honour of presenting the first study in the PIVOT Study Series at The Haemophilia Society Big Get Together 2024 - an event that brings together stakeholders from the bleeding disorders community to discuss initiatives in the name of advancing the understanding and treatment of bleeding disorders. During the session, Sam shared a sneak peek of the interim results from the PIVOT-vWD study, marking a significant milestone in the project focused on the most common bleeding disorder, von Willebrand Disease (vWD). We’re grateful to the team at The Haemophilia Society, including Kate Burt, Debra Morgan, Dr Joanne Traunter and Hannah Yarnall, to name a few, for their dedication to progressing research in vWD and creating a platform for collaboration. Our team is excited to continue this journey and looks forward to developing further studies and sharing more findings in the new year! Including our ISPOR—The Professional Society for Health Economics and Outcomes Research Europe abstract focused on one of the rarest bleeding disorders, Glanzmann's Thrombasthenia. Thank you to all who attended and contributed to the conversation today. #BIGGETTOGETHER #PIVOTStudy #vWD #ResearchInAction #BleedingDisorders #Collaboration #HealthcareInnovation #PIVOTvWD #TheHaemophiliaSociety

𝐄𝐱𝐩𝐥𝐨𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐑𝐨𝐥𝐞 𝐨𝐟 𝐏𝐚𝐭𝐢𝐞𝐧𝐭-𝐆𝐞𝐧𝐞𝐫𝐚𝐭𝐞𝐝 𝐃𝐚𝐭𝐚 𝐢𝐧 𝐄𝐯𝐢𝐝𝐞𝐧𝐜𝐞-𝐁𝐚𝐬𝐞𝐝 𝐂𝐚𝐫𝐞 As we head to 𝐈𝐒𝐏𝐎𝐑 𝐄𝐔 2024, our team at 𝐃𝐇𝐓.𝐡𝐞𝐚𝐥𝐭𝐡 is excited to discuss the expanding role of patient-generated data and preferences in shaping healthcare decisions across Europe. With the growing emphasis on real-world insights, there’s a significant opportunity to ensure that healthcare not only meets clinical standards but also aligns with patient experiences and needs. In our latest article, we explore: ⚫ Why patient-generated data is key to personalising healthcare decisions ⚫ How patient preferences are shaping the future of HEOR ⚫ What’s needed to bring patient perspectives into evidence-based care sustainably https://lnkd.in/eHkURZpV We’re especially looking forward to these two sessions at ISPOR EU 24 that delve into this important topic further: Monday, 18 November, 10:15 - 11:15: Should We Account for Variation in Patient Preferences in Health Technology Assessment? Wednesday, 20 November, 08:00 - 09:00: Integrating the Patient Voice Into Economic Assessments of Health Technologies 📅 Reach out to schedule a time with us at ISPOR EU 2024. We’d love to connect and discuss how we can support you with our research team. #ISPOREU2024 #HEOR #PatientCentredResearch #DHThealth #PatientPreference #PatientData #EvidenceBasedCare

𝐏𝐫𝐢𝐨𝐭𝐢𝐳𝐞 𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐏𝐫𝐞𝐟𝐞𝐫𝐞𝐧𝐜𝐞𝐬 Patient preference research helps shape target product profiles by focusing on what truly matters to patients. Discover how this approach can differentiate your product and prioritize patient needs. 𝘋𝘪𝘷𝘦 𝘪𝘯𝘵𝘰 𝘵𝘩𝘦 𝘧𝘶𝘭𝘭 𝘢𝘳𝘵𝘪𝘤𝘭𝘦 𝘷𝘪𝘢 𝘵𝘩𝘦 𝘭𝘪𝘯𝘬 𝘪𝘯 𝘵𝘩𝘦 𝘤𝘰𝘮𝘮𝘦𝘯𝘵𝘴.

Incorporating patient preferences is essential for creating patient-centered treatments. Explore the value & methods of patient preference elicitation research. 🌐 Check out the article in the comments below! Feel free to reach out to the DHT.health team and connect if you have any questions or insights! 🔗 #PatientPreferences #HEOR #Elicitation #PatientCenteredCare #PatientVoice

🌟 Embracing Patient-Centricity in Healthcare: The Role of Patient Preference Research in Target Product Profiles 🌟 In today’s rapidly evolving healthcare landscape, patient-centricity is not just a trend; it’s the foundation of successful product development. One of the most powerful ways to adopt this patient-first mindset is through patient preference research, which plays a crucial role in informing the creation of a Target Product Profile (TPP). 📝 What is a TPP? A TPP outlines the desired attributes of a new drug or device, serving as a roadmap for development aligning stakeholders and setting clear goals that streamline the complex journey of bringing a new therapy to market. 🔍 Why Patient Preferences Matter: ⚪ Identifying Meaningful Attributes: Engage with patients to discover which product features truly matter to them. ⚪ Prioritizing Trade-offs: Understand the difficult choices patients face and fine-tune product attributes to reflect what they value most. ⚪Enhancing Market Differentiation: A patient-focused TPP helps your product stand out in a competitive marketplace. As healthcare moves towards a more collaborative model, listening to patient voices becomes critical for long-term success. Let’s prioritize patient voices in product development! Interested in how to make your TPP more patient-focused? See the article below and let’s connect! 💬 https://lnkd.in/dWaZyNHq #PatientCentricity #HealthcareInnovation #PatientPreferenceResearch #ProductDevelopment #HEOR #TargetProductProfile